Pembrolizumab-associated expansion of radiation-induced morphoea responsive to dupilumab: a case report

Jordan T Said; Christopher Iriarte; Jordan Talia; Bonnie Leung; Cesar A Virgen; Matthew Robertson; Michael S Rabin; Cecilia Larocca; Nicole R LeBoeuf

doi:10.1093/ced/llad164

Pembrolizumab-associated expansion of radiation-induced morphoea responsive to dupilumab: a case report

Clin Exp Dermatol. 2023 Aug 25;48(9):1077-1080. doi: 10.1093/ced/llad164.

Authors

Jordan T Said^{1

2

3}, Christopher Iriarte^{1

2

3}, Jordan Talia¹, Bonnie Leung^{1

3}, Cesar A Virgen^{1

2

3}, Matthew Robertson^{2

4}, Michael S Rabin^{2

5}, Cecilia Larocca^{1

2

3}, Nicole R LeBoeuf^{1

2

3}

Affiliations

¹ Departments of Dermatology.
² Harvard Medical School, Boston, MA, USA.
³ Center for Cutaneous Oncology.
⁴ Radiology, Brigham and Women's Hospital, Boston, MA, USA.
⁵ Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

PMID: 37119266
DOI: 10.1093/ced/llad164

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Lung Neoplasms*
Scleroderma, Localized*

Substances

pembrolizumab
dupilumab
Antibodies, Monoclonal, Humanized